Net income of DexCom under GAAP for the 3 months of 2022 was $97.3 million, up 72.2% from $56.5 million in the previous year. Revenue increased 24.5% to $628.8 million from $505 million a year earlier.

DexCom's board of directors plans to conduct a 4:1 split of the common stock. If approved by shareholders at the May 19, 2022 meeting, the number of shares will increase from 200 million to 800 million. Trading of the shares with the split is scheduled to begin June 10, 2022.

DexCom's GAAP net income for 2021 was $154.7 million, down 3.2 times from $493.6 billion in the previous year. Revenues rose 27.1% to $2.449 billion from $1.927 billion a year earlier.

DexCom reported net income of $174.1 million for 9M 2021, up 25.8% from $138.4 million in the previous year. Revenues increased 28.9% to $1.75 billion from $1.358 billion a year earlier.